Investor mix
16 investors on record; lead investors include T. Rowe Price, Deerfield; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 50% |
| Private equity | 4 | 25% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 3 | 19% |
Innovative medicines company reimagining medicine to improve and extend people's lives
16 investors on record; lead investors include T. Rowe Price, Deerfield; 4 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 8 | 50% |
| Private equity | 4 | 25% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 3 | 19% |